临床路径模式下定额与非定额支付方式应用于3个病种的用药成效对比分析

发布时间：2018-10-04 20:57

【摘要】：目的:探讨临床路径模式下定额支付方式与非定额支付方式应用于临床用药的成效差异。方法:采用回顾性调查方法,抽取2012年1-9月我院临床路径模式下定额支付管理(定额组)的自然临产阴道分娩病例298例、计划性剖宫产病例113例及胆囊良性病变择期手术病例83例;抽取2014年1-6月我院临床路径模式下非定额支付管理(非定额组)的自然阴道分娩病例404例、计划性剖宫产病例126例及胆囊良性病变择期手术病例155例。收集定额组及非定额组3个病种的临床用药情况,运用SPSS19.0软件处理分析其差异性。结果:定额组的3个病种在住院费用、药品费用方面均低于非定额组(P0.05或P0.01);胆囊良性病变择期手术定额组的平均住院日短于非定额组(P0.01)。结论:临床路径模式下定额支付方式在确保患者治疗效果及用药安全的同时,能有效降低患者的医疗及药品费用。
[Abstract]:Objective: to explore the difference between the application of quota payment and non-quota payment in clinical pathway. Methods: a retrospective study was conducted to select 298 cases of spontaneous vaginal delivery in our hospital from January to September 2012 under quota payment management (quota group). 113 cases of planned cesarean section and 83 cases of elective operation for benign gallbladder diseases were selected, 404 cases of spontaneous vaginal delivery were selected from January to June 2014 in our hospital under the mode of non-quota payment management (non-quota group). There were 126 cases of planned cesarean section and 155 cases of elective operation for benign diseases of gallbladder. The clinical drug use of the three diseases in the quota group and the non-quota group was collected and the difference was analyzed by SPSS19.0 software. Results: the hospitalization cost and drug cost of the three diseases in the quota group were lower than those in the non-quota group (P0.05 or P0.01), and the average hospitalization days in the elective operation quota group for benign gallbladder diseases were shorter than those in the non-quota group (P0.01). Conclusion: under the mode of clinical pathway, the method of quota payment can effectively reduce the medical treatment and drug cost of patients while ensuring the efficacy and safety of drug use.
【作者单位】：重庆市黔江中心医院药学部;
【分类号】：R95

【相似文献】